|
CLNS1A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.026100E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.226400E-02 |
| Normal-vs-Stage2 |
5.067600E-01 |
| Normal-vs-Stage3 |
9.590800E-04 |
| Normal-vs-Stage4 |
1.324250E-03 |
| Stage1-vs-Stage2 |
4.053600E-01 |
| Stage1-vs-Stage3 |
3.751700E-02 |
| Stage1-vs-Stage4 |
3.882200E-02 |
| Stage2-vs-Stage3 |
2.852200E-02 |
| Stage2-vs-Stage4 |
3.939900E-02 |
| Stage3-vs-Stage4 |
8.522600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.059800E-02 |
| Normal-vs-AfricanAmerican |
5.265800E-01 |
| Normal-vs-Asian |
3.675600E-02 |
| Caucasian-vs-AfricanAmerican |
3.157200E-01 |
| Caucasian-vs-Asian |
9.070000E-01 |
| AfricanAmerican-vs-Asian |
2.816400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.344400E-01 |
| Normal-vs-Female |
3.881000E-03 |
| Male-vs-Female |
1.205590E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.539170E-01 |
| Normal-vs-Age(41-60Yrs) |
2.473600E-02 |
| Normal-vs-Age(61-80Yrs) |
9.076900E-03 |
| Normal-vs-Age(81-100Yrs) |
1.232100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.045400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.596040E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.285180E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.072200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.429850E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.739200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.564300E-03 |
| Classical-VS-Follicular |
1.921430E-01 |
| Classical-VS-Other |
7.186400E-01 |
| Classical-VS-Normal |
2.217700E-02 |
| Tall-VS-Follicular |
1.782620E-03 |
| Tall-VS-Other |
3.241000E-01 |
| Tall-VS-Normal |
2.849000E-04 |
| Follicular-VS-Other |
8.973200E-01 |
| Follicular-VS-Normal |
4.375200E-01 |
| Other-VS-Normal |
5.918000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.159600E-02 |
| Normal-vs-N1 |
3.60729999999698E-05 |
| N0-vs-N1 |
1.956530E-03 |
|
|
